Fanyan Meng

机构：Nanjing Drum Tower Hospital · ORCID：0009-0001-4717-8506

发表论文 47 篇 · 总被引 151 次 · h-index 8

代表论文

• Enzymatically responsive nanocarriers targeting PD-1 and TGF-β pathways reverse immunotherapeutic resistance and elicit robust therapeutic efficacy (2025 · Journal of Nanobiotechnology · 被引 20)
• An Immunomodulator‐Boosted Lactococcus Lactis Platform For Enhanced In Situ Tumor Vaccine (2024 · Advanced Healthcare Materials · 被引 7)
• Multiplex immunohistochemistry to explore the tumor immune microenvironment in HCC patients with different GPC3 expression (2025 · Journal of Translational Medicine · 被引 6)
• Personalized tumor-informed circulating tumor DNA monitoring for early detection of recurrence in postoperative pancreatic cancer (2026 · Frontiers in Oncology · 被引 1)
• 1172 Human TROP2 protein and circRNA vaccines inhibit tumor growth in TROP2-humanized mouse models (2025 · Regular and Young Investigator Award Abstracts · 被引 1)
• Nanomodified Switch Induced Precise and Moderate Activation of CAR‐T Cells for Solid Tumors (Adv. Sci. 12/2023) (2023 · Advanced Science · 被引 1)